Sarasota, FL4 Active Studies

Atrial Fibrillation Clinical Trials in Sarasota, FL

Find 4 actively recruiting atrial fibrillation clinical trials in Sarasota, FL. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
2,197
Enrolling

Recruiting Atrial Fibrillation Studies in Sarasota

About Atrial Fibrillation Clinical Trials in Sarasota

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 4 atrial fibrillation clinical trials recruiting participants in Sarasota, FL. These studies are seeking a combined 2,197 participants. Research is being sponsored by AtriCure, Inc., Eli Lilly and Company, Heart Rhythm Clinical and Research Solutions, LLC and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Sarasota — FAQ

Are there atrial fibrillation clinical trials in Sarasota?

Yes, there are 4 atrial fibrillation clinical trials currently recruiting in Sarasota, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sarasota?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sarasota research site will contact you about next steps.

Are clinical trials in Sarasota free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sarasota studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 4 active trials in Sarasota are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated July 18, 2026 from ClinicalTrials.gov